Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-06-000607
Filing Date
2006-07-27
Accepted
2006-07-27 15:42:05
Documents
3
Period of Report
2006-07-27

Document Format Files

Seq Description Document Type Size
1 SECOND QUARTER REPORT FOR THE QUARTER ENDED JUNE 30, 2006 o32490e6vk.htm 6-K 240714
2 GRAPHIC o32490o3249000.gif GRAPHIC 11267
3 GRAPHIC o32490o3249001.gif GRAPHIC 1882
  Complete submission text file 0001130319-06-000607.txt   260557
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 06984485
SIC: 2834 Pharmaceutical Preparations